Type 2 Diabetes

An analysis of more than 1 million singleton births in Denmark is detailing a potential association between maternal diabetes and increased risk of developing an eating disorder early in life.

Patients who are prescribed metformin may face a risk of urticaria, though the latter can be treated with antihistamines.

An analysis of data from a California health survey suggests non-obese Vietnamese Americans were 60% more likely to have diabetes as their non-obese non-Hispanic White counterparts.

Only 29.5% of sampled CBD users claimed any wellness benefit.

An analysis of data from more than 9 million women details the increased odds of developing gestational diabetes, gestational hypertension, and other complications associated with having polycystic ovary syndrome.

A study presented at UEG Week 2020 suggests a minimally-invasive, outpatient procedure combined with GLP-1 RA therapy could help diabetics eliminate the need for insulin therapy.

An analysis of Explorys data presented at UEG Week 2020 suggests bariatric surgery in obese diabetics could reduce risk of pancreatic cancer.

A meta-analysis published in JAMA Cardiology details reductions in cardiovascular and kidney outcomes associated with SGLT2 inhibitor use in diabetes patients.

This episode of the Endocrine Outlook podcast features a discussion around the cardiorenal benefits of SGLT2 inhibitors and GLP-1 receptor agonists.

An analysis of data from DiRECT suggests diabetes remission was linked to restoration of pancreas size and function.

An analysis of the Look AHEAD Study suggests improved blood sugar control was linked to improved executive function and neurologic health among patients with type 2 diabetes.

Muthiah Vaduganathan, MD, MPH, of Brigham and Women's discusses the barriers to preventing optimal prescribing practices for SGLT2 inhibitor and GLP-1 receptor agonist therapies.

A trial of patients with prediabetes and OSA details the cardiovascular benefit of optimized CPAP treatment.

An RCT of patients with prediabetes and OSA details the cardiovascular benefit of optimized CPAP treatment in this patient population.

Gregory Weiss, MD, reflects on the idea of creating a cardiometabolic subspecialty.

An analysis of nationally representative data suggests 35.6% of diabetic patients reported not receiving a yearly influenza vaccination.

Results of a study of more than 330 patients suggest use of sitagliptin could improve outcomes in patients with diabetes and COVID-19.

This edition from the 10 Year Plan features perspective from leadership at ACC and ESC, as well as survey results from cardiologists.

An analysis of nearly 300k offspring suggests those exposed to diabetes in the womb were at an increased risk of cardiovascular disease events and risk factors in young adulthood.

Ongoing trials are essential to confirming semalutide’s role in decreasing risk of chronic kidney disease in patients with type 2 diabetes

An analysis of data from 5 major databases suggests NRTIs could reduce incidence of type 2 diabetes.

An associate professor from University of Toronto discusses whose responsibility it is to prescribe SGLT2 inhibitors to patients.

A study presented at EASD 2020 examines the impact of increased exercise capacity on risk of all-cause mortality among more than 4k patients with type 2 diabetes.

Analysis of information from more than 1000 patients in Australia sheds light on the potential association between metformin use and slower cognitive decline in older individuals.

Data from a group of type 1 diabetics from a diabetes center in Italy suggests time off work and in lockdown could have been helped some patients improve glycemic control.

Research presented at EASD 2020 provides an updated estimate of the life years lost as a result of type 1 and type 2 diabetes, respectively, among patients in the UK.

A study from EASD 2020 found type 1 diabetes was associated with a 33% increase in risk of falls while type 2 diabetes was associated with a 19% increase in risk.

A study from EASD 2020 suggests patients with RA could be at a nearly 25% increase in risk of developing type 2 diabetes later in life.

New research suggests children treated with high-doses of oral glucocorticoids could be at a greater risk of diabetes, hypertension, and venous thromboembolism.

Analysis of data from a European aging study suggests feeling lonely was linked to an increased risk of developing diabetes in older adults.